Clinical Trials Logo

Clinical Trial Summary

The Building Resilience and Vital Equity (BRAVE) project seeks to partner with American Indian tribal communities in North Carolina to establish COVID-19 services and resources for American Indian communities. The goal of this study is to 1) understand the barriers and social implications of COVID19 testing and vaccination among American Indians by designing and implementing culturally sensitive survey tools and intervention materials; 2) Implement BRAVE outreach and testing interventions to increase testing in American Indian communities; 3) analyze data and share back with tribal communities to improve perceptions of COVID-19 testing in the AI community and decrease in vaccine hesitancy.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04964154
Study type Interventional
Source North Carolina Central University
Contact Deepak Kumar, PhD
Phone 919-530-7017
Email dkumar@ad.nccu.edu
Status Recruiting
Phase N/A
Start date February 17, 2021
Completion date June 30, 2022

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05087225 - Suspicion of Hypoglycemic Effect of mRNA Based Covid-19 Vaccines (Polyethylene Glycol) Will Happen , Observational Study on Diabetic Patients at Saudia Arabia
Recruiting NCT04790240 - Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID) Phase 1/Phase 2